Raymond James & Associates’s Synaptics SYNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,401
| Closed | -$653K | – | 4101 |
|
|
2024
Q2 | $653K | Buy |
7,401
+327
| +5% | +$29.6K | ﹤0.01% | 2901 |
|
|
2024
Q1 | $690K | Sell |
7,074
-6,868
| -49% | -$722K | ﹤0.01% | 2857 |
|
|
2023
Q4 | $1.59M | Buy |
13,942
+5,093
| +58% | +$505K | ﹤0.01% | 2236 |
|
|
2023
Q3 | $791K | Buy |
8,849
+369
| +4% | +$32.4K | ﹤0.01% | 2609 |
|
|
2023
Q2 | $724K | Sell |
8,480
-2,484
| -23% | -$216K | ﹤0.01% | 2683 |
|
|
2023
Q1 | $1.22M | Buy |
10,964
+1,935
| +21% | +$223K | ﹤0.01% | 2339 |
|
|
2022
Q4 | $859K | Sell |
9,029
-93
| -1% | -$8.94K | ﹤0.01% | 2524 |
|
|
2022
Q3 | $903K | Buy |
9,122
+60
| +0.7% | +$7.45K | ﹤0.01% | 2467 |
|
|
2022
Q2 | $1.07M | Buy |
9,062
+4,491
| +98% | +$658K | ﹤0.01% | 2388 |
|
|
2022
Q1 | $912K | Buy |
4,571
+1,495
| +49% | +$332K | ﹤0.01% | 2668 |
|
|
2021
Q4 | $891K | Sell |
3,076
-34
| -1% | -$8.12K | ﹤0.01% | 2690 |
|
|
2021
Q3 | $559K | Buy |
3,110
+335
| +12% | +$56.3K | ﹤0.01% | 2989 |
|
|
2021
Q2 | $432K | Sell |
2,775
-25
| -0.9% | -$3.38K | ﹤0.01% | 3196 |
|
|
2021
Q1 | $379K | Buy |
+2,800
| New | +$341K | ﹤0.01% | 3209 |
|
|
2020
Q4 | – | Sell |
-8,286
| Closed | -$666K | – | 3870 |
|
|
2020
Q3 | $666K | Buy |
+8,286
| New | +$655K | ﹤0.01% | 2441 |
|
|
2020
Q2 | – | Sell |
-5,052
| Closed | -$292K | – | 3660 |
|
|
2020
Q1 | $292K | Buy |
+5,052
| New | +$343K | ﹤0.01% | 2795 |
|
|
2018
Q3 | – | Sell |
-13,748
| Closed | -$692K | – | 3714 |
|
|
2018
Q2 | $692K | Sell |
13,748
-10,552
| -43% | -$479K | ﹤0.01% | 2459 |
|
|
2018
Q1 | $1.11M | Sell |
24,300
-50,096
| -67% | -$2.27M | ﹤0.01% | 2060 |
|
|
2017
Q4 | $2.97M | Sell |
74,396
-2,816
| -4% | -$108K | 0.01% | 1428 |
|
|
2017
Q3 | $3.02M | Buy |
77,212
+11,508
| +18% | +$519K | 0.01% | 1356 |
|
|
2017
Q2 | $3.4M | Buy |
65,704
+10,737
| +20% | +$586K | 0.01% | 1239 |
|
|
2017
Q1 | $2.72M | Sell |
54,967
-298
| -0.5% | -$16K | 0.01% | 1354 |
|
|
2016
Q4 | $2.96M | Buy |
55,265
+3,218
| +6% | +$186K | 0.01% | 1251 |
|
|
2016
Q3 | $3.05M | Buy |
52,047
+4,739
| +10% | +$260K | 0.01% | 1215 |
|
|
2016
Q2 | $2.54M | Sell |
47,308
-443
| -0.9% | -$30.4K | 0.01% | 1201 |
|
|
2016
Q1 | $3.81M | Buy |
47,751
+427
| +0.9% | +$32.4K | 0.01% | 963 |
|
|
2015
Q4 | $3.8M | Sell |
47,324
-1,293
| -3% | -$110K | 0.01% | 938 |
|
|
2015
Q3 | $4.01M | Buy |
48,617
+2,058
| +4% | +$156K | 0.02% | 851 |
|
|
2015
Q2 | $4.04M | Buy |
46,559
+3,612
| +8% | +$330K | 0.02% | 916 |
|
|
2015
Q1 | $3.49M | Sell |
42,947
-26,537
| -38% | -$2M | 0.02% | 927 |
|
|
2014
Q4 | $4.78M | Buy |
69,484
+10,536
| +18% | +$705K | 0.02% | 702 |
|
|
2014
Q3 | $4.32M | Sell |
58,948
-4,423
| -7% | -$361K | 0.02% | 701 |
|
|
2014
Q2 | $5.74M | Sell |
63,371
-6,600
| -9% | -$447K | 0.04% | 572 |
|
|
2014
Q1 | $4.2M | Buy |
69,971
+3,893
| +6% | +$231K | 0.03% | 649 |
|
|
2013
Q4 | $3.42M | Buy |
66,078
+16,967
| +35% | +$832K | 0.03% | 688 |
|
|
2013
Q3 | $2.17M | Buy |
+49,111
| New | +$2.01M | 0.02% | 837 |
|
Other funds holding SYNA
OAG
TI
Raymond James & Associates's SYNA Position: Q3 2024 in Review
Raymond James & Associates sold out of Synaptics (SYNA) in Q3 2024, closing a stake of 7,401 shares — an estimated $653K sold.
Raymond James & Associates first reported a position in SYNA in Q3 2013 and held it in 36 quarters. The position peaked at $5.74M in Q2 2014. 267 funds tracked by Wall St. Rank hold SYNA as of Q3 2024.
- Raymond James & Associates reported no remaining Synaptics position as of Q3 2024 after selling out during the quarter.
- Raymond James & Associates sold 7,401 Synaptics shares in Q3 2024, an estimated $653K.
- Raymond James & Associates first reported a position in Synaptics in Q3 2013 and held it in 36 quarters.
- Raymond James & Associates's Synaptics position peaked at $5.74M in Q2 2014.
- 267 funds tracked by Wall St. Rank held Synaptics as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.